Compounds > simvastatin
Page last updated: 2024-08-23

simvastatin and Adenocarcinoma, Clear Cell

simvastatin has been researched along with Adenocarcinoma, Clear Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuura, M; Saito, T; Suzuki, T1
Ito, E; Matsuura, M; Saito, T; Suzuki, M; Suzuki, T; Tanaka, R1

Other Studies

2 other study(ies) available for simvastatin and Adenocarcinoma, Clear Cell

ArticleYear
Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy.
    Cancer science, 2010, Volume: 101, Issue:8

    Topics: Adenocarcinoma, Clear Cell; Cell Line, Tumor; Extracellular Matrix; Female; Humans; Integrins; Neoplasm Invasiveness; Osteopontin; Ovarian Neoplasms; RNA Interference; Simvastatin

2010
Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
    Oncology reports, 2011, Volume: 25, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Mice; Osteopontin; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Simvastatin; Xenograft Model Antitumor Assays

2011